Feng Luo
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Metal complexes synthesis and properties
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 15
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 3
- Drug Transport and Resistance Mechanisms 2
- Cancer Cells and Metastasis 2
-
- Wnt/β-catenin signaling in development and cancer 4
- S100 Proteins and Annexins 2
- Co-authors
- Stephen G. Chaney (5 shared papers)Steven D. Wyrick (4 shared papers)Kunping Liu (5 shared papers)Jinbang Li (5 shared papers)Jean Lu (3 shared papers)Patrick J. Sinko (2 shared papers)Wenxin Zheng (2 shared papers)Ailan Guo (2 shared papers)
- Journals
- Clinical Cancer Research (4 papers)Cancer Chemotherapy and Pharmacology (4 papers)International Journal of Oncology (2 papers)Scientific Reports (2 papers)Magnetic Resonance in Medicine (1 paper)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Feng Luo
36 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 99
- Oncology 471
- Reproductive Medicine 131
- Hematology 155
- Genetics 99
- Molecular Biology 425
Countries citing papers authored by Feng Luo
This map shows the geographic impact of Feng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Luo more than expected).
Fields of papers citing papers by Feng Luo
This network shows the impact of papers produced by Feng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Luo. The network helps show where Feng Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 125 | |
| 2 | 2006 | 115 | |
| 3 | 2016 | 89 | |
| 4 | 2009 | 87 | |
| 5 | 2002 | 86 | |
| 6 | 2005 | 66 | |
| 7 | 2006 | 65 | |
| 8 | 2005 | 59 | |
| 9 | 1999 | 56 | |
| 10 | 2002 | 55 | |
| 11 | 2004 | 54 | |
| 12 | 2001 | 49 | |
| 13 | 2008 | 43 | |
| 14 | 1999 | 41 | |
| 15 | 1999 | 38 | |
| 16 | 1999 | 29 | |
| 17 | Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity. | 2002 | 27 |
| 18 | 2019 | 26 | |
| 19 | 2014 | 24 | |
| 20 | 2020 | 23 |
About Feng Luo
Feng Luo is a scholar working on Oncology, Molecular Biology, Genetics, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 36 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers), Alzheimer's disease research and treatments (3 papers), HER2/EGFR in Cancer Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), S100 Proteins and Annexins (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Oncology (471 citations), Reproductive Medicine (131 citations), Hematology (155 citations), Genetics (99 citations) and Molecular Biology (425 citations). Feng Luo has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Stephen G. Chaney, Steven D. Wyrick, Kunping Liu, Jinbang Li, Jean Lu, Patrick J. Sinko, Wenxin Zheng, Ailan Guo, Eric H. Rubin and Anne Blackwood‐Chirchir. Their work appears in journals such as Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, International Journal of Oncology, Scientific Reports and Magnetic Resonance in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.